POLYTECH Health & Aesthetics, a global leader in breast implant innovation, has announced the establishment of a direct subsidiary in the United Kingdom. This strategic investment reinforces POLYTECH’s commitment to providing world-class aesthetics and breast reconstruction solutions in one of Europe’s most important markets.
With this expansion, surgeons and patients across the UK will now have direct access to POLYTECH’s differentiated product portfolio, including B-Lite, the world’s only lightweight breast implants, as well as the highly regarded MESMO and Microthane implants—recognised globally for their innovation, safety, and quality.
Suitable for both cosmetic and reconstructive surgery, B-Lite breast implants are up to 30% lighter than traditional implants, meaning up to 50% less pressure on the breast for patients, resulting in quicker recovery time and increased comfort.
Prof. Dr. Karsten Hemmrich, CEO of POLYTECH Health & Aesthetics, commented: “We are incredibly excited to deepen our presence in the UK. Beyond expanding our aesthetics business, we are committed to strengthening our partnerships with NHS hospitals in breast reconstruction. Women recovering from breast cancer in the UK will significantly benefit from our unique breast reconstruction solutions, as both B-Lite and Microthane implants are clinically proven to deliver outstanding long-term results.”
The newly established UK team will be led by Richard Graham, Regional Director Business Development, a seasoned industry expert with extensive experience in the UK and European markets.
“Richard’s strong relationships with top surgeons and medical institutions, both public and private, make him the ideal leader for this expansion. We are confident that under his leadership, our UK team will successfully drive POLYTECH’s ambitious growth and impact in the region,” Prof. Hemmrich concluded.
